Summary of results
| Number of patients | ROSC | 30-day survival | Survival to discharge | 1-year survival | |
|---|---|---|---|---|---|
| Total | 113 | 68 (60.1%) | 27 (23.9%) | 27 (23.9%) | 26 (23.0%) |
| Clinical frailty scale pooled | |||||
| 1–3 (not frail) | 35 | 30 (85.7%) | 16 (45.7%) | 16 (45.7%) | 16 (45.7%) |
| 4 (pre-frail) | 15 | 8 (53.3%) | 3 (20.0%) | 3 (20.0%) | 3 (20.0%) |
| 5–9 (frail) | 39 | 21 (58%) | 5 (12.8%) | 5 (12.8%) | 4 (10.3%) |
| Cardiology patients clinical frailty scale pooled | |||||
| 1–3 (not frail) | 18 | 17 | 13 (72.2%) | 13 (72.2%) | 13 (72.2%) |
| 4 (pre-frail) | 6 | 3 | 2 (33.3%) | 2 (33.3%) | 2 (33.3%) |
| 5–9 (frail) | 6 | 6 | 3 (50.0%) | 3 (50.0%) | 2 (33.3%) |
| Total | 30 | 26 (86.7) | 18 (60.0%) | 18 (60.0%) | 17 (56.7%) |
| ANOVA p value | 0.573 | 0.356 | 0.356 | 0.060 | |
| Non-cardiology patients clinical frailty scale pooled | |||||
| 1–3 (not frail) | 17 | 13 (76.5%) | 3 (17.6%) | 3 (17.6%) | 3 (17.6%) |
| 4 (pre-frail) | 9 | 5 (55.6%) | 1 (11.1%) | 1 (11.1%) | 1 (11.1%) |
| 5–9 (frail) | 33 | 15 (45.5%) | 2 (6.1%) | 2 (6.1%) | 2 (6.1%) |
| Total | 59 | 33 (55.9%) | 6 (10.2%) | 6 (10.2%) | 6 (10.2%) |
| Charlson (pooled) | |||||
| 0 | 1 | 1 (100%) | 1 (100%) | 1 (100%) | 1 (100%) |
| 1–3 | 18 | 14 (77.8%) | 8 (44.4%) | 8 (44.4%) | 8 (44.4%) |
| >4 | 89 | 52 (58.4) | 18 (20.2%) | 18 (20.2%) | 17 (19.1%) |
| Charlson (pooled) cardiology patients | |||||
| 0 | 1 | 1 (100%) | 1 (100%) | 1 (100%) | 1 (100%) |
| 1–3 | 7 | 7 (100%) | 7 (100%) | 7 (100%) | 7 (100%) |
| >4 | 31 | 24 (77.4%) | 14 (45.2%) | 14 (45.2%) | 13 (41.9%) |
| Charlson (pooled) non-cardiology patients | |||||
| 0 | 0 | 0 | 0 | 0 | 0 |
| 1–3 | 11 | 7 (63.6%) | 1 (9.1%) | 1 (9.1%) | 1 (9.1%) |
| >4 | 58 | 10 (17.2%) | 4 (6.9%) | 4 (6.9%) | 4 (6.9%) |
ROSC = return of spontaneous circulation.